Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women

Table 1 Inclusion and Exclusion criteria for subjects in study

Inclusion Criteria	Exclusion Criteria
• Women in first 5 years of menopause	• BMO T Score < -2.5 at hip or spine (osteoporosis)
• BMD T score between -1.0 and -2.49 at total hip or L1L4 spine (osteoporosis)	• Increased hip and major fracture based on FRAX score
• 19 years of age or older	• Bisphosphonates in last 6 months
• Health care provider’s permission to be in study	• Currently on estrogen, tamoxifen, Aromatase Inhibitors, others
	• Weight > 300 pounds
	• Serum Vitamin D <10 ng/ml or >100 ng/ml
	• Any conditions that prohibit optimal CaD, risedronate, or exercise

ISSN: 1472-6874